Neo Ivy Capital Management Buys Shares of 100,470 Avantor, Inc. (NYSE:AVTR)

Neo Ivy Capital Management acquired a new position in Avantor, Inc. (NYSE:AVTR - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 100,470 shares of the company's stock, valued at approximately $2,116,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Rhumbline Advisers increased its stake in shares of Avantor by 1.8% during the fourth quarter. Rhumbline Advisers now owns 1,922,368 shares of the company's stock worth $40,504,000 after purchasing an additional 33,692 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Avantor by 2.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 3,027,636 shares of the company's stock valued at $63,792,000 after acquiring an additional 74,735 shares in the last quarter. Blue Trust Inc. boosted its stake in shares of Avantor by 6.9% in the fourth quarter. Blue Trust Inc. now owns 8,069 shares of the company's stock worth $170,000 after acquiring an additional 522 shares during the last quarter. Robeco Institutional Asset Management B.V. increased its position in shares of Avantor by 38.1% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 119,063 shares of the company's stock worth $2,509,000 after purchasing an additional 32,838 shares in the last quarter. Finally, Rhenman & Partners Asset Management AB increased its position in shares of Avantor by 40.5% during the fourth quarter. Rhenman & Partners Asset Management AB now owns 61,826 shares of the company's stock worth $1,303,000 after purchasing an additional 17,826 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company's stock.

Insider Buying and Selling at Avantor

In related news, Director Joseph R. Massaro purchased 8,100 shares of the business's stock in a transaction dated Tuesday, April 29th. The stock was acquired at an average price of $12.30 per share, for a total transaction of $99,630.00. Following the completion of the purchase, the director now directly owns 35,038 shares of the company's stock, valued at $430,967.40. This trade represents a 30.07% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Gregory L. Summe acquired 20,000 shares of the business's stock in a transaction on Thursday, May 22nd. The shares were purchased at an average price of $12.65 per share, with a total value of $253,000.00. Following the transaction, the director now owns 70,000 shares in the company, valued at $885,500. The trade was a 40.00% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders bought 83,100 shares of company stock worth $1,027,630. 1.20% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on AVTR. Barclays lowered their target price on shares of Avantor from $18.00 to $15.00 and set an "overweight" rating on the stock in a research note on Monday, April 28th. Cowen cut shares of Avantor from a "buy" rating to a "hold" rating in a research note on Monday, April 28th. Raymond James reissued an "outperform" rating and issued a $24.00 target price (down from $26.00) on shares of Avantor in a research note on Monday, February 10th. Morgan Stanley lowered Avantor from an "overweight" rating to an "equal weight" rating in a research report on Tuesday, April 29th. Finally, TD Cowen downgraded Avantor from a "buy" rating to a "hold" rating and set a $15.50 price objective on the stock. in a research report on Monday, April 28th. Seven equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $18.88.

Avantor Stock Down 0.6%

Avantor stock traded down $0.08 during midday trading on Wednesday, reaching $13.08. The company's stock had a trading volume of 2,585,892 shares, compared to its average volume of 7,912,816. The company has a market cap of $8.91 billion, a P/E ratio of 12.57, a P/E/G ratio of 1.55 and a beta of 1.09. The company has a quick ratio of 0.70, a current ratio of 1.07 and a debt-to-equity ratio of 0.54. The business has a 50-day simple moving average of $14.29 and a 200-day simple moving average of $18.12. Avantor, Inc. has a fifty-two week low of $11.82 and a fifty-two week high of $28.00.

Avantor (NYSE:AVTR - Get Free Report) last announced its quarterly earnings results on Friday, April 25th. The company reported $0.23 EPS for the quarter, hitting the consensus estimate of $0.23. Avantor had a net margin of 10.49% and a return on equity of 12.17%. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.61 billion. During the same period last year, the business earned $0.22 EPS. Avantor's revenue for the quarter was down 5.9% compared to the same quarter last year. On average, research analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.